Annual report
3079.TEDINET S100R5FJ
Period2022-04-01 → 2023-03-31
Filed2023-06-28
StandardJapan GAAP
ConsolidatedNo
Data checks13 of 13 passed
Key figures · 88
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥47.5bn | 2022-04-01 → 2023-03-31 | Standalone | Net sales |
| Revenue | ¥45.5bn | 2021-04-01 → 2022-03-31 | Standalone | Net sales |
| Revenue | ¥41.0bn | 2020-04-01 → 2021-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥44.7bn | 2019-04-01 → 2020-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥40.4bn | 2018-04-01 → 2019-03-31d | Standalone | Net sales (5-year summary) |
| Operating income | ¥1.3bn | 2022-04-01 → 2023-03-31 | Standalone | Operating income |
| Operating income | ¥1.3bn | 2021-04-01 → 2022-03-31 | Standalone | Operating income |
| Ordinary income | ¥1.4bn | 2022-04-01 → 2023-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥1.3bn | 2021-04-01 → 2022-03-31 | Standalone | Ordinary income |
| Profit before tax | ¥1.4bn | 2022-04-01 → 2023-03-31 | Standalone | Income before income taxes |
| Profit before tax | ¥1.3bn | 2021-04-01 → 2022-03-31 | Standalone | Income before income taxes |
| Net income | ¥936m | 2022-04-01 → 2023-03-31 | Standalone | Profit loss |
| Net income | ¥863m | 2021-04-01 → 2022-03-31 | Standalone | Profit loss |
| Net income | ¥572m | 2020-04-01 → 2021-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥792m | 2019-04-01 → 2020-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥974m | 2018-04-01 → 2019-03-31d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥23.6bn | at 2023-03-31 | Standalone | Assets |
| Total assets | ¥22.2bn | at 2022-03-31 | Standalone | Assets |
| Total assets | ¥20.6bn | at 2021-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥20.4bn | at 2020-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥18.6bn | at 2019-03-31d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥14.3bn | at 2023-03-31 | Standalone | Liabilities |
| Total liabilities | ¥13.6bn | at 2022-03-31 | Standalone | Liabilities |
| Net assets / equity | ¥9.3bn | at 2023-03-31 | Standalone | Net assets |
| Net assets / equity | ¥8.6bn | at 2022-03-31 | Standalone | Net assets |
| Net assets / equity | ¥7.9bn | at 2021-03-31d | Standalone | Net assets |
| Net assets / equity | ¥7.6bn | at 2020-03-31d | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥7.5bn | at 2019-03-31d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥8.6bn | at 2023-03-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥7.8bn | at 2022-03-31 | Standalone | Cash and deposits |
| Cash & equivalents | ¥8.6bn | at 2023-03-31 | Standalone | Cash and cash equivalents |
| Cash & equivalents | ¥7.8bn | at 2022-03-31 | Standalone | Cash and cash equivalents |
| Cash & equivalents | ¥6.5bn | at 2021-03-31d | Standalone | Cash and cash equivalents |
| Cash & equivalents | ¥5.2bn | at 2020-03-31d | Standalone | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥5.3bn | at 2019-03-31d | Standalone | Cash and cash equivalents (5-year summary) |
| Operating cash flow | ¥1.5bn | 2022-04-01 → 2023-03-31 | Standalone | Net cash provided by used in operating activities |
| Operating cash flow | ¥1.7bn | 2021-04-01 → 2022-03-31 | Standalone | Net cash provided by used in operating activities |
| Operating cash flow | ¥1.7bn | 2020-04-01 → 2021-03-31d | Standalone | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥1.0bn | 2019-04-01 → 2020-03-31d | Standalone | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥290m | 2018-04-01 → 2019-03-31d | Standalone | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥477m | 2022-04-01 → 2023-03-31 | Standalone | Net cash provided by used in investment activities |
| Investing cash flow | −¥97m | 2021-04-01 → 2022-03-31 | Standalone | Net cash provided by used in investment activities |
| Investing cash flow | −¥217m | 2020-04-01 → 2021-03-31d | Standalone | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥362m | 2019-04-01 → 2020-03-31d | Standalone | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥195m | 2018-04-01 → 2019-03-31d | Standalone | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | −¥245m | 2022-04-01 → 2023-03-31 | Standalone | Net cash provided by used in financing activities |
| Financing cash flow | −¥235m | 2021-04-01 → 2022-03-31 | Standalone | Net cash provided by used in financing activities |
| Financing cash flow | −¥274m | 2020-04-01 → 2021-03-31d | Standalone | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥747m | 2019-04-01 → 2020-03-31d | Standalone | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥910m | 2018-04-01 → 2019-03-31d | Standalone | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥90.21 | 2022-04-01 → 2023-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥83.56 | 2021-04-01 → 2022-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥55.6 | 2020-04-01 → 2021-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥75.56 | 2019-04-01 → 2020-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥88.46 | 2018-04-01 → 2019-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥90.04 | 2022-04-01 → 2023-03-31 | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥83.33 | 2021-04-01 → 2022-03-31 | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥55.5 | 2020-04-01 → 2021-03-31d | Standalone | Diluted earnings per share (5-year summary) |
| Dividend per share | ¥30 | 2022-04-01 → 2023-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥25 | 2021-04-01 → 2022-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥24 | 2020-04-01 → 2021-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥24 | 2019-04-01 → 2020-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥24 | 2018-04-01 → 2019-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥894.19 | at 2023-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥828.27 | at 2022-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥767.76 | at 2021-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥735.76 | at 2020-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥689.18 | at 2019-03-31d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 39.4% | at 2023-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 38.6% | at 2022-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 38.5% | at 2021-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 37.1% | at 2020-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 40.0% | at 2019-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 10.5% | 2022-04-01 → 2023-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 10.5% | 2021-04-01 → 2022-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 7.4% | 2020-04-01 → 2021-03-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 10.5% | 2019-04-01 → 2020-03-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 13.1% | 2018-04-01 → 2019-03-31d | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 10,780,000 | at 2023-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 10,780,000 | at 2022-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 10,780,000 | at 2021-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 11,280,000 | at 2020-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 11,280,000 | at 2019-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 319 | at 2023-03-31 | Standalone | Number of employees |
| Employees | 328 | at 2022-03-31 | Standalone | Number of employees |
| Employees | 330 | at 2021-03-31d | Standalone | Number of employees |
| Employees | 322 | at 2020-03-31d | Standalone | Number of employees |
| Employees | 302 | at 2019-03-31d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 17
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2022-04-01 → 2023-03-31 | ¥3.6bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2022-04-01 → 2023-03-31 | ¥3.6bn |
| Arrhythmia Businessreportable segment | revenue | 2022-04-01 → 2023-03-31 | ¥40.9bn |
| Arrhythmia Businessreportable segment | revenue external | 2022-04-01 → 2023-03-31 | ¥40.9bn |
| Ischemia Businessreportable segment | revenue | 2022-04-01 → 2023-03-31 | ¥3.1bn |
| Ischemia Businessreportable segment | revenue external | 2022-04-01 → 2023-03-31 | ¥3.1bn |
| —segment total | revenue | 2022-04-01 → 2023-03-31 | ¥43.9bn |
| —segment total | revenue external | 2022-04-01 → 2023-03-31 | ¥43.9bn |
| Total Of Reportable Segments And Otherssegment total | employees | at 2023-03-31 | 319 pure |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2021-04-01 → 2022-03-31 | ¥2.9bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2021-04-01 → 2022-03-31 | ¥2.9bn |
| Arrhythmia Businessreportable segment | revenue | 2021-04-01 → 2022-03-31 | ¥39.4bn |
| Arrhythmia Businessreportable segment | revenue external | 2021-04-01 → 2022-03-31 | ¥39.4bn |
| Ischemia Businessreportable segment | revenue | 2021-04-01 → 2022-03-31 | ¥3.2bn |
| Ischemia Businessreportable segment | revenue external | 2021-04-01 → 2022-03-31 | ¥3.2bn |
| —segment total | revenue | 2021-04-01 → 2022-03-31 | ¥42.6bn |
| —segment total | revenue external | 2021-04-01 → 2022-03-31 | ¥42.6bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 930
| Item | Context | Value | Unit |
|---|---|---|---|
| Telephone number address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)03－5985－6123(代表) | |
| Name of contact person address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)取締役 宮本 聡 | |
| Nearest place of contact cover page | FilingDateInstant | Original text (Japanese)東京都豊島区高田二丁目17番22号 | |
| Telephone number nearest place of contact cover page | FilingDateInstant | Original text (Japanese)03－5985－6123(代表) | |
| Name of contact person nearest place of contact cover page | FilingDateInstant | Original text (Japanese)取締役 宮本 聡 | |
| Place for public inspection cover page (text) | FilingDateInstant | Text · Plus | |
| Edinet code | FilingDateInstant | E03005 | |
| Fund code | FilingDateInstant | － | |
| Security code | FilingDateInstant | 30790 | |
| Filer name in japanese | FilingDateInstant | Original text (Japanese)ディーブイエックス株式会社 | |
| Filer name in english | FilingDateInstant | DVx Inc. | |
| Fund name in japanese | FilingDateInstant | － | |
| Fund name in english | FilingDateInstant | － | |
| Cabinet office ordinance | FilingDateInstant | Original text (Japanese)企業内容等の開示に関する内閣府令 | |
| Document type | FilingDateInstant | Original text (Japanese)第三号様式 | |
| Accounting standards | FilingDateInstant | Japan GAAP | |
| Whether consolidated financial statements are prepared | FilingDateInstant | false | |
| Industry code when consolidated financial statements are prepared in accordance with industry specific regulations | FilingDateInstant | － | |
| Industry code when financial statements are prepared in accordance with industry specific regulations | FilingDateInstant | cte | |
| Current fiscal year start date | FilingDateInstant | 2022-04-01 | |
| Current period end date | FilingDateInstant | 2023-03-31 | |
| Type of current period | FilingDateInstant | FY | |
| Current fiscal year end date | FilingDateInstant | 2023-03-31 | |
| Previous fiscal year start date | FilingDateInstant | 2021-04-01 | |
| Comparative period end date | FilingDateInstant | 2022-03-31 | |
| Previous fiscal year end date | FilingDateInstant | 2022-03-31 | |
| Next fiscal year start date | FilingDateInstant | － | |
| End date of quarterly or semi annual period of next fiscal year | FilingDateInstant | － | |
| Amendment flag | FilingDateInstant | false | |
| Identification of document subject to amendment | FilingDateInstant | － | |
| Report amendment flag | FilingDateInstant | false | |
| Xbrl amendment flag | FilingDateInstant | false | |
| Business results of reporting company (text) | FilingDateInstant | Text · Plus | |
| Company history (text) | FilingDateInstant | Text · Plus | |
| Description of business (text) | FilingDateInstant | Text · Plus | |
| Overview of affiliated entities (text) | FilingDateInstant | Text · Plus | |
| Information about employees (text) | FilingDateInstant | Text · Plus | |
| Business policy business environment issues to address etc (text) | FilingDateInstant | Text · Plus | |
| Disclosure of sustainability related financial information (text) | FilingDateInstant | Text · Plus | |
| Governance (text) | FilingDateInstant | Text · Plus | |
| Risk management (text) | FilingDateInstant | Text · Plus | |
| Strategy (text) | FilingDateInstant | Text · Plus | |
| Metrics and targets (text) | FilingDateInstant | Text · Plus | |
| Reference to other information strategy | FilingDateInstant | Original text (Japanese)３ 事業等のリスク | |
| Description of metrics related to policy on human resource development and improvement of internal environment and targets and results using such metrics metrics and targets (text) | FilingDateInstant | Text · Plus | |
| Business risks (text) | FilingDateInstant | Text · Plus | |
| Management analysis of financial position operating results and cash flows (text) | FilingDateInstant | Text · Plus | |
| Critical contracts for operation (text) | FilingDateInstant | Text · Plus | |
| Research and development activities (text) | FilingDateInstant | Text · Plus | |
| Overview of capital expenditures etc (text) | FilingDateInstant | Text · Plus |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 13 of 13 passed
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |